Tag: AC Immune

Roche and AC Immune Stop Trials of Alzheimer’s Drug

Roche and AC Immune have discontinued phase III trials of their Alzheimer’s disease drug crenezumab after an interim analysis indicated it would not hit its primary endpoint. Crenezumab is an anti-...

Lilly and AC Immune to Develop Tau-Targeting Alzheimer’s Drug

Eli Lilly has paid $81m to develop drugs targeting aggregation of tau proteins associated with Alzheimer’s with Swiss biotech AC Immune, as focus shifts away from therapies targeting clumps of amyloid...